Chinese CRO firm PharmaLegacy nets nearly $100m

Chinese CRO firm PharmaLegacy nets nearly $100m

Chinese contract development organisation PharmaLegacy has received approximately $100 million in a fresh round of financing.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter